DVA
DAVITA INC.
NYSE · Healthcare · Medical - Care Facilities · US
$188.75
+3.61%Next report
Analyst consensus
- Next report date
- Feb 1, 2027
- EPS estimate
- $4.20
- Revenue estimate
- $3.6B
Latest reported
- Last report date
- Oct 29, 2026
- EPS actual
- $3.82
- EPS estimate
- $3.57
- Revenue actual
- $3.6B
- Revenue estimate
- $3.5B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +8.7%
- Revenue beats (12Q)
- 7
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $237
- PT range
- $215 – $287
- Analysts
- 4
2 Buy2 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 29, 2026 | $3.57 | $3.82 | Beat 7.00% | $3.6B |
| Aug 4, 2026 | $3.88 | $4.02 | Beat 3.61% | $3.6B |
| May 5, 2026 | $2.41 | $2.87 | Beat 19.09% | $3.4B |
| Feb 2, 2026 | $3.24 | $3.40 | Beat 4.94% | $3.6B |
| Oct 29, 2025 | $3.17 | $2.51 | Miss -20.82% | $3.4B |
| Feb 13, 2025 | $2.14 | $2.24 | Beat 4.67% | $3.3B |
| May 2, 2024 | $1.95 | $2.26 | Beat 15.90% | $3.1B |
| Feb 13, 2024 | $1.59 | $1.62 | Beat 1.89% | $3.1B |
| Aug 3, 2023 | $1.69 | $1.91 | Beat 13.02% | $3.0B |
| Feb 22, 2023 | $0.88 | $1.11 | Beat 26.14% | $2.9B |
| Oct 28, 2022 | $1.65 | $1.45 | Miss -12.12% | $2.9B |
| Aug 1, 2022 | $2.09 | $2.30 | Beat 10.05% | $2.9B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 1, 2027